Health and Fitness Health and Fitness
Mon, May 7, 2012
Sat, May 5, 2012
Fri, May 4, 2012
Thu, May 3, 2012
[ Thu, May 03rd 2012 ] - Market Wire
00 p.m. EDT
Wed, May 2, 2012
[ Wed, May 02nd 2012 ] - Market Wire
Location Change
Tue, May 1, 2012
Mon, April 30, 2012
[ Mon, Apr 30th 2012 ] - Market Wire
Hologic to Acquire Gen-Probe
Sun, April 29, 2012
Sat, April 28, 2012
Fri, April 27, 2012
Thu, April 26, 2012
Wed, April 25, 2012
Tue, April 24, 2012
Mon, April 23, 2012

Anthera Announces First Quarter 2012 Financial Report and Conference Call


//health-fitness.news-articles.net/content/2012/ .. r-2012-financial-report-and-conference-call.html
Published in Health and Fitness on Friday, April 27th 2012 at 9:08 GMT by Market Wire   Print publication without navigation


Anthera Announces First Quarter 2012 Financial Report and Conference Call -- HAYWARD, Calif., April 27, 2012 /PRNewswire/ --

Anthera Announces First Quarter 2012 Financial Report and Conference Call

[ ]

HAYWARD, Calif., April 27, 2012 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: [ ANTH ]), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, will release its first quarter 2012 financial report after market close on Thursday, May 3, 2012. Anthera will host a conference call at 8:30 am Eastern Time on Friday, May 4, 2012.

Conference Call Access:
Date: Friday, May 4, 2012
Time: 8:30 am Eastern Time

Domestic Dial-in: (877) 312-8807
International Dial-in: (253) 237-1190
Conference ID: 76225935

To access the 24-hour audio replay, U.S. and Canadian participants may dial (855) 859-2056; international participants may dial (404) 537-3406. The conference ID for the replay is 76225935. The audio replay will be available until May 11, 2012. 

About Anthera Pharmaceuticals

Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation and autoimmune diseases.

CONTACT: Bianca Nery of Anthera Pharmaceuticals, Inc., [ bnery@anthera.com ] or 510-856-5586.

SOURCE Anthera Pharmaceuticals, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.anthera.com ]


Publication Contributing Sources